ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 178 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,692,234 | -24.6% | 137,411 | 0.0% | 0.40% | +19.8% |
Q2 2023 | $4,900,076 | +40.4% | 137,411 | 0.0% | 0.34% | +39.7% |
Q1 2023 | $3,490,239 | +62527.7% | 137,411 | 0.0% | 0.24% | -62.3% |
Q4 2022 | $5,573 | -99.9% | 137,411 | 0.0% | 0.64% | +28.1% |
Q3 2022 | $4,541,000 | -6.1% | 137,411 | 0.0% | 0.50% | +3.1% |
Q2 2022 | $4,838,000 | -23.4% | 137,411 | 0.0% | 0.49% | +11.7% |
Q1 2022 | $6,320,000 | -30.6% | 137,411 | 0.0% | 0.44% | -20.8% |
Q4 2021 | $9,110,000 | +6.2% | 137,411 | 0.0% | 0.55% | +42.6% |
Q3 2021 | $8,579,000 | -24.6% | 137,411 | 0.0% | 0.38% | -21.9% |
Q2 2021 | $11,380,000 | +24.9% | 137,411 | 0.0% | 0.49% | +54.1% |
Q1 2021 | $9,112,000 | -42.1% | 137,411 | -33.0% | 0.32% | -54.4% |
Q4 2020 | $15,737,000 | -36.6% | 205,091 | -64.4% | 0.70% | -51.1% |
Q3 2020 | $24,824,000 | -0.3% | 576,505 | 0.0% | 1.44% | -19.6% |
Q2 2020 | $24,899,000 | +12.6% | 576,505 | -25.0% | 1.78% | -10.9% |
Q1 2020 | $22,115,000 | -69.8% | 768,674 | -72.2% | 2.00% | -70.8% |
Q2 2019 | $73,277,000 | +71.5% | 2,765,153 | +18.8% | 6.87% | +61.2% |
Q1 2019 | $42,728,000 | +47.7% | 2,328,475 | 0.0% | 4.26% | +15.4% |
Q4 2018 | $28,920,000 | -35.2% | 2,328,475 | 0.0% | 3.69% | -17.9% |
Q3 2018 | $44,637,000 | +72.7% | 2,328,475 | +22.6% | 4.50% | +35.1% |
Q2 2018 | $25,840,000 | +88.6% | 1,900,000 | 0.0% | 3.33% | +71.6% |
Q1 2018 | $13,699,000 | – | 1,900,000 | – | 1.94% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $20,836,128 | 14.83% |
Aquilo Capital Management, LLC | 1,018,474 | $25,869,240 | 10.72% |
Rokos Capital Management LLP | 1,675,921 | $41,537,702 | 3.07% |
COMMODORE CAPITAL LP | 575,000 | $14,605,000 | 2.22% |
Privium Fund Management B.V. | 259,036 | $6,579,514 | 2.21% |
JOHNSON & JOHNSON | 247,598 | $6,288,989 | 2.05% |
WEALTH EFFECTS LLC | 156,810 | $3,982,976 | 2.04% |
M28 Capital Management LP | 67,400 | $1,711,960 | 1.94% |
Evolutionary Tree Capital Management, LLC | 51,878 | $1,317,701 | 1.83% |
Avidity Partners Management LP | 1,741,300 | $44,229,020 | 1.47% |